Cathay Historical Cash Flow
| 688065 Stock | 42.02 0.48 1.13% |
Analysis of Cathay Biotech cash flow over time is an excellent tool to project Cathay Biotech future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 4.7 B or Depreciation of 209.9 M as it is a great indicator of Cathay Biotech ability to facilitate future growth, repay debt on time or pay out dividends.
Cathay |
About Cathay Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Cathay balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cathay's non-liquid assets can be easily converted into cash.
Cathay Biotech Cash Flow Chart
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Cathay Biotech's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Cathay Biotech current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Cathay Biotech's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Other Non Cash Items is expected to grow to about 10.3 M, whereas Investments are forecasted to decline to (1.6 B).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 1.5B | 4.2B | 1.6B | 1.9B | Dividends Paid | 339.6M | 206.9M | 137.7M | 178.1M |
Cathay Biotech cash flow statement Correlations
Click cells to compare fundamentals
Cathay Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Other Information on Investing in Cathay Stock
The Cash Flow Statement is a financial statement that shows how changes in Cathay balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cathay's non-liquid assets can be easily converted into cash.